BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 36575500)

  • 1. Identification of circulating miRNAs differentially expressed in patients with Limb-girdle, Duchenne or facioscapulohumeral muscular dystrophies.
    García-Giménez JL; García-Trevijano ER; Avilés-Alía AI; Ibañez-Cabellos JS; Bovea-Marco M; Bas T; Pallardó FV; Viña JR; Zaragozá R
    Orphanet J Rare Dis; 2022 Dec; 17(1):450. PubMed ID: 36575500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Profiling of 179 miRNA Expression in Serum from Limb Girdle Muscular Dystrophy Patients and Healthy Controls.
    Magri F; Napoli L; Ripolone M; Ciscato P; Moggio M; Corti S; Comi GP; Sciacco M; Zanotti S
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three novel serum biomarkers, miR-1, miR-133a, and miR-206 for Limb-girdle muscular dystrophy, Facioscapulohumeral muscular dystrophy, and Becker muscular dystrophy.
    Matsuzaka Y; Kishi S; Aoki Y; Komaki H; Oya Y; Takeda S; Hashido K
    Environ Health Prev Med; 2014 Nov; 19(6):452-8. PubMed ID: 25150707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perturbation of muscle metabolism in patients with muscular dystrophy in early or acute phase of disease: In vitro, high resolution NMR spectroscopy based analysis.
    Srivastava NK; Yadav R; Mukherjee S; Sinha N
    Clin Chim Acta; 2018 Mar; 478():171-181. PubMed ID: 29278724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum miRNAs as biomarkers for the rare types of muscular dystrophy.
    Koutsoulidou A; Koutalianos D; Georgiou K; Kakouri AC; Oulas A; Tomazou M; Kyriakides TC; Roos A; Papadimas GK; Papadopoulos C; Kararizou E; Spyrou GM; Zamba Papanicolaou E; Lochmüller H; Phylactou LA
    Neuromuscul Disord; 2022 Apr; 32(4):332-346. PubMed ID: 35393236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal lipid metabolism in skeletal muscle tissue of patients with muscular dystrophy: In vitro, high-resolution NMR spectroscopy based observation in early phase of the disease.
    Srivastava NK; Yadav R; Mukherjee S; Pal L; Sinha N
    Magn Reson Imaging; 2017 May; 38():163-173. PubMed ID: 28069416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNAs as a Tool for Differential Diagnosis of Neuromuscular Disorders.
    Mousa NO; Abdellatif A; Fahmy N; El-Fawal H; Osman A
    Neuromolecular Med; 2023 Dec; 25(4):603-615. PubMed ID: 37856057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of the North Star Assessment for Limb-Girdle Type Muscular Dystrophies.
    James MK; Alfano LN; Muni-Lofra R; Reash NF; Sodhi J; Iammarino MA; Moat D; Shannon K; McCallum M; Richardson M; Eagle M; Straub V; Marini-Bettolo C; Lowes LP; Mayhew AG
    Phys Ther; 2022 Oct; 102(10):. PubMed ID: 35932452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of the peripheral blood levels of circulating microRNAs with both recurrent miscarriage and the outcomes of embryo transfer in an in vitro fertilization process.
    Yang Q; Gu WW; Gu Y; Yan NN; Mao YY; Zhen XX; Wang JM; Yang J; Shi HJ; Zhang X; Wang J
    J Transl Med; 2018 Jul; 16(1):186. PubMed ID: 29973278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upper extremity function and activity in facioscapulohumeral dystrophy and limb-girdle muscular dystrophies: a systematic review.
    Bergsma A; Cup EH; Geurts AC; de Groot IJ
    Disabil Rehabil; 2015; 37(12):1017-32. PubMed ID: 25098592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The sensitivity of exome sequencing in identifying pathogenic mutations for LGMD in the United States.
    Reddy HM; Cho KA; Lek M; Estrella E; Valkanas E; Jones MD; Mitsuhashi S; Darras BT; Amato AA; Lidov HG; Brownstein CA; Margulies DM; Yu TW; Salih MA; Kunkel LM; MacArthur DG; Kang PB
    J Hum Genet; 2017 Feb; 62(2):243-252. PubMed ID: 27708273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic status of patients with muscular dystrophy in early phase of the disease: In vitro, high resolution NMR spectroscopy based metabolomics analysis of serum.
    Srivastava NK; Annarao S; Sinha N
    Life Sci; 2016 Apr; 151():122-129. PubMed ID: 26930370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different profiles of upper limb function in four types of neuromuscular disorders.
    Bergsma A; Janssen MMHP; Geurts ACH; Cup EHC; de Groot IJM
    Neuromuscul Disord; 2017 Dec; 27(12):1115-1122. PubMed ID: 29033278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural history of circulating miRNAs in Duchenne disease: Association with muscle injury and metabolic parameters.
    Almeida-Becerril T; Rodríguez-Cruz M; Hernández-Cruz SY; Ruiz-Cruz ED; Mendoza CRS; Cárdenas-Conejo A; Escobar-Cedillo RE; Ávila-Moreno F; Aquino-Jarquin G
    Acta Neurol Scand; 2022 Nov; 146(5):512-524. PubMed ID: 36000352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RETINAL VASCULAR DISEASE IN LIMB-GIRDLE MUSCULAR DYSTROPHY.
    Shaheen AR; Yannuzzi NA; Kennedy T; Yannuzzi LA
    Retin Cases Brief Rep; 2024 Jan; 18(1):39-42. PubMed ID: 36007191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical, pathological, imaging, and genetic characterization in a Taiwanese cohort with limb-girdle muscular dystrophy.
    Liang WC; Jong YJ; Wang CH; Wang CH; Tian X; Chen WZ; Kan TM; Minami N; Nishino I; Wong LC
    Orphanet J Rare Dis; 2020 Jun; 15(1):160. PubMed ID: 32576226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Open Label Exploratory Clinical Trial Evaluating Safety and Tolerability of Once-Weekly Prednisone in Becker and Limb-Girdle Muscular Dystrophy.
    Zelikovich AS; Joslin BC; Casey P; McNally EM; Ajroud-Driss S
    J Neuromuscul Dis; 2022; 9(2):275-287. PubMed ID: 35124660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating miR-206 as a Biomarker for Patients Affected by Severe Limb Girdle Muscle Dystrophies.
    Pegoraro V; Angelini C
    Genes (Basel); 2021 Jan; 12(1):. PubMed ID: 33445560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole-exome sequencing identifies novel pathogenic mutations and putative phenotype-influencing variants in Polish limb-girdle muscular dystrophy patients.
    Fichna JP; Macias A; Piechota M; Korostyński M; Potulska-Chromik A; Redowicz MJ; Zekanowski C
    Hum Genomics; 2018 Jul; 12(1):34. PubMed ID: 29970176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defective regulation of microRNA target genes in myoblasts from facioscapulohumeral dystrophy patients.
    Dmitriev P; Stankevicins L; Ansseau E; Petrov A; Barat A; Dessen P; Robert T; Turki A; Lazar V; Labourer E; Belayew A; Carnac G; Laoudj-Chenivesse D; Lipinski M; Vassetzky YS
    J Biol Chem; 2013 Dec; 288(49):34989-5002. PubMed ID: 24145033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.